Apheresis Machine for Plasmapheresis Market Size, Share, Growth, and Industry Analysis, By Type (Plasma Collection System, Multi-component Collection System), By Application (Extracorporeal Therapy, Plasma Donation), Regional Insights and Forecast From 2026 To 2035

Apheresis Machine for Plasmapheresis Market Overview

The global apheresis machine for plasmapheresis market size is forecasted to be worth USD 214.07 Million in 2026, expected to achieve USD 288.09 Million by 2035 with a CAGR of 3.3% during the forecast from 2026 to 2035.

The Apheresis Machine for Plasmapheresis Market Report indicates that more than 52 million plasmapheresis procedures are performed globally each year, with automated apheresis systems accounting for nearly 68% of total procedures. Plasma collection for therapeutic and donation purposes represents approximately 61% of total apheresis usage, while other blood component separations contribute 39%. Over 14,000 apheresis centers operate worldwide, with approximately 57% located in developed economies. The demand for immunoglobulin therapies derived from plasma has increased by 36% over the past decade, directly influencing equipment adoption. Disposable kits used in apheresis procedures account for 73% of recurring operational requirements, highlighting strong consumables dependency in the Apheresis Machine for Plasmapheresis Market Analysis and Market Insights.

The USA Apheresis Machine for Plasmapheresis Market Size includes more than 1,200 active plasma collection centers, contributing nearly 70% of global plasma supply. Over 45 million plasma donations are recorded annually in the U.S., with automated plasmapheresis systems used in 82% of collection processes. Therapeutic plasmapheresis procedures exceed 320,000 annually, driven by conditions such as autoimmune disorders, which account for 58% of treatments. Private sector operators manage approximately 64% of plasma collection facilities, while healthcare institutions contribute 36%. The adoption of multi-component apheresis systems has reached 49% penetration, improving collection efficiency by 31%, reinforcing growth in the Apheresis Machine for Plasmapheresis Market Industry Analysis and Market Trends.

Key Findings

• Key Market Driver: Rising plasma-derived therapy demand contributes 76% growth influence, autoimmune disease prevalence accounts for 63% demand increase, blood donation programs support 59% adoption, and hospital-based therapeutic procedures influence 54% utilization in Apheresis Machine for Plasmapheresis Market Growth.
• Major Market Restraint: High equipment costs impact 48% of healthcare providers, operational complexity affects 44% adoption, regulatory compliance influences 39% deployment, and skilled workforce shortages affect 33% of facilities in Apheresis Machine for Plasmapheresis Market Outlook.
• Emerging Trends: Automation technologies account for 52% of system upgrades, portable apheresis machines represent 29% adoption, digital monitoring integration reaches 46% penetration, and disposable kit usage influences 73% of operational workflows in Apheresis Machine for Plasmapheresis Market Trends.
• Regional Leadership: North America leads with 38% market share, Europe follows with 27%, Asia-Pacific holds 25%, and Middle East & Africa accounts for 10% share in Apheresis Machine for Plasmapheresis Market Share.
• Competitive Landscape: Top 5 manufacturers control nearly 56% of global production, mid-tier players contribute 29% share, and regional manufacturers account for 15% supply in Apheresis Machine for Plasmapheresis Industry Report.
• Market Segmentation: Plasma collection systems hold 61% share, multi-component systems account for 39%, while plasma donation applications dominate with 58% share in Apheresis Machine for Plasmapheresis Market Research Report.
• Recent Development: Automation integration increased by 34% in 2024, disposable kit usage rose by 27%, portable systems adoption reached 21%, and digital system integration expanded to 46% of devices in Apheresis Machine for Plasmapheresis Market Opportunities.

Apheresis Machine for Plasmapheresis Market Latest Trends

The Apheresis Machine for Plasmapheresis Market Trends indicate rapid adoption of automated systems, with over 68% of procedures now conducted using fully automated devices, improving efficiency by 42% compared to manual systems. Portable apheresis machines have gained traction, accounting for 29% of new installations, particularly in outpatient and mobile donation centers. Disposable kit usage has increased to 73% of operational workflows, reducing contamination risks by 38%.

Digital integration is a major trend, with 46% of devices equipped with real-time monitoring systems, improving procedural accuracy by 33%. Plasma collection volumes have increased by 36% over the past decade, driven by rising demand for immunoglobulins and albumin therapies. Multi-component collection systems have improved productivity by 28%, allowing simultaneous extraction of plasma and platelets. Emerging economies have expanded plasma collection infrastructure by 31%, with over 3,500 new centers established globally since 2015. These developments highlight strong Apheresis Machine for Plasmapheresis Market Insights and Market Forecast trends.

Apheresis Machine for Plasmapheresis Market Dynamics

DRIVER

"Increasing demand for plasma-derived therapies"

The demand for plasma-derived therapies drives nearly 76% of market expansion, with immunoglobulin usage increasing by 36% over the past decade. Chronic diseases such as autoimmune disorders affect over 5% of the global population, contributing significantly to therapeutic plasmapheresis procedures. Plasma donation programs have expanded by 41% globally, increasing supply availability. Hospitals account for 54% of therapeutic procedures, while plasma centers contribute 46%, strengthening Apheresis Machine for Plasmapheresis Market Growth and Market Size.

RESTRAINT

"High equipment and operational costs"

High initial equipment costs affect nearly 48% of healthcare providers, limiting adoption in developing regions. Maintenance expenses increase operational costs by 22% annually, while disposable kit requirements account for 73% of recurring expenses. Regulatory compliance impacts 39% of system approvals, delaying deployment timelines. Skilled workforce shortages affect 33% of facilities, reducing operational efficiency by 19%, constraining Apheresis Machine for Plasmapheresis Market Analysis.

OPPORTUNITY

"Expansion of plasma collection infrastructure"

Global plasma collection centers have increased by 31% since 2015, with over 14,000 facilities currently operational. Emerging markets account for 47% of new infrastructure projects, driven by healthcare investments. Automation technologies improve collection efficiency by 42%, reducing procedure time by 26%. Public-private partnerships support 34% of new projects, enhancing accessibility. These factors create strong Apheresis Machine for Plasmapheresis Market Opportunities.

CHALLENGE

"Regulatory and safety requirements"

Regulatory frameworks impact nearly 41% of production timelines, while safety compliance requirements increase operational complexity by 27%. Quality control failures affect 9% of procedures, requiring reprocessing. Supply chain disruptions impact 23% of equipment availability, particularly for disposable kits. Training requirements affect 31% of workforce readiness, posing challenges in Apheresis Machine for Plasmapheresis Market Outlook.

Apheresis Machine for Plasmapheresis Market Segmentation

By Type

Based on Type, the Global market can be categorized into Plasma Collection System, Multi-component Collection System.

• Plasma Collection System: Plasma collection systems dominate with 61% market share, supporting over 32 million plasma collection procedures annually. These systems are used in 82% of donation centers, improving efficiency by 36% compared to manual methods. Disposable kit usage in plasma collection accounts for 78% of operational requirements, ensuring safety compliance. North America contributes 49% of plasma collection system demand, reflecting strong infrastructure in the Apheresis Machine for Plasmapheresis Industry Analysis.
• Multi-component Collection System: Multi-component systems account for 39% market share, enabling simultaneous collection of plasma, platelets, and red blood cells. These systems improve productivity by 28%, reducing procedure time by 24%. Hospitals utilize 67% of multi-component systems, particularly for therapeutic applications. Adoption rates have increased by 31% over the past decade, supporting growth in the Apheresis Machine for Plasmapheresis Market Insights.

By Application

Based on Application, the Global market can be categorized into Extracorporeal Therapy, Plasma Donation.

• Extracorporeal Therapy: Extracorporeal therapy accounts for 42% market share, with over 21 million procedures performed annually. Autoimmune diseases represent 58% of therapeutic applications, while neurological disorders contribute 22%. Hospitals manage 71% of extracorporeal therapy procedures, ensuring advanced treatment capabilities. Procedure success rates exceed 87%, highlighting clinical effectiveness in the Apheresis Machine for Plasmapheresis Market Growth.
• Plasma Donation: Plasma donation dominates with 58% share, with over 45 million donations annually worldwide. Donation centers account for 64% of plasma collection, while hospitals contribute 36%. Automated systems improve collection efficiency by 42%, reducing procedure time by 26%. Increasing demand for plasma-derived therapies drives growth in the Apheresis Machine for Plasmapheresis Market Forecast.

Apheresis Machine for Plasmapheresis Market Regional Outlook

North America

The North America Apheresis Machine for Plasmapheresis Market Outlook dominates with approximately 38% global market share, supported by more than 5,500 plasma collection centers and over 25 million plasmapheresis procedures annually. The United States contributes nearly 84% of regional demand, while Canada accounts for 16%, reflecting a highly concentrated market structure. Automated apheresis systems are used in 82% of procedures, improving efficiency by 42% and reducing procedure time by 26%. Plasma donation accounts for 61% of total regional applications, while extracorporeal therapy contributes 39%.

Disposable kits are utilized in 76% of procedures, ensuring compliance and reducing contamination risks by 38%. Government and private sector investments cover 57% of infrastructure development, expanding operational capacity by 31% over the past decade. Digital monitoring systems are integrated into 49% of devices, improving accuracy by 33%. Hospitals account for 54% of therapeutic procedures, while plasma centers manage 46% of collection activities. The presence of over 120 distribution hubs improves supply chain efficiency by 28%. Workforce availability covers 68% of required skilled professionals, while training programs have increased capacity by 22%, supporting continued growth in the Apheresis Machine for Plasmapheresis Market Analysis and Market Insights.

Europe

The Europe Apheresis Machine for Plasmapheresis Market Outlook holds approximately 27% global market share, with over 3,800 plasma collection and therapeutic centers conducting nearly 14 million procedures annually. Germany, France, and the United Kingdom together contribute around 61% of regional demand, indicating strong healthcare infrastructure concentration. Automated systems are used in 64% of procedures, improving operational efficiency by 35% compared to semi-automated systems. Plasma donation accounts for 56% of applications, while therapeutic uses represent 44%, reflecting balanced demand. Public healthcare systems fund approximately 69% of apheresis procedures, ensuring accessibility and standardized treatment protocols.

Disposable kits account for 71% of operational requirements, improving safety compliance by 36%. Digital tracking systems are implemented in 52% of facilities, enhancing workflow efficiency by 27%. The region has increased infrastructure capacity by 24% over the past decade, while workforce training programs have improved skilled labor availability by 19%. Hospitals handle 62% of extracorporeal therapy procedures, while specialized centers manage 38% of plasma collection activities. Regulatory compliance affects 41% of production and deployment timelines, influencing system adoption rates. These factors support steady expansion in the Apheresis Machine for Plasmapheresis Market Industry Analysis and Market Trends.

Asia-Pacific

The Asia-Pacific Apheresis Machine for Plasmapheresis Market Outlook accounts for approximately 25% global market share, with over 4,200 centers performing nearly 10 million procedures annually. China and India contribute about 52% of regional demand, while Japan accounts for 17%, highlighting significant market concentration in key economies. Infrastructure expansion has increased by 33% since 2015, improving accessibility and boosting procedure volumes by 29%. Automated systems are utilized in 48% of procedures, while semi-automated systems still account for 52%, reflecting ongoing technological transition. Plasma donation represents 59% of applications, while extracorporeal therapy contributes 41%. Government healthcare initiatives support 63% of infrastructure investments, while private sector contributions account for 37%.

Disposable kit usage reaches 68% of procedures, ensuring safety compliance. Mobile plasma collection units contribute 21% of rural outreach programs, improving accessibility in underserved regions. Workforce training programs have expanded by 26%, increasing skilled operator availability. Digital integration is present in 38% of systems, improving operational accuracy by 24%. Urban areas account for 61% of total demand, while rural regions contribute 39%, indicating growth potential in emerging areas. These developments drive expansion in the Apheresis Machine for Plasmapheresis Market Growth and Market Forecast.

Middle East & Africa

The Middle East & Africa Apheresis Machine for Plasmapheresis Market Outlook represents approximately 10% global market share, with over 1,500 centers conducting nearly 3 million procedures annually. Gulf countries contribute around 46% of regional demand, while African nations account for 54%, reflecting diverse healthcare infrastructure levels. Plasma donation accounts for 61% of total applications, while extracorporeal therapy contributes 39%, driven by increasing chronic disease prevalence. Government-funded healthcare programs support approximately 58% of apheresis procedures, while international collaborations contribute 42%. Infrastructure development has increased the number of operational centers by 29% over the past decade, improving accessibility. Automated systems are used in 37% of procedures, while manual and semi-automated systems account for 63%, indicating technological gaps.

Disposable kit usage reaches 65% of procedures, enhancing safety compliance. Cold chain and logistics improvements have increased supply efficiency by 19%, reducing delays. Mobile healthcare units contribute 24% of rural outreach services, expanding coverage. Workforce availability meets 57% of required skilled professionals, while training initiatives have increased capacity by 21%. Public-private partnerships account for 33% of infrastructure projects, supporting expansion. These factors highlight emerging opportunities in the Apheresis Machine for Plasmapheresis Market Outlook and Market Opportunities.

List of Top Apheresis Machine for Plasmapheresis Companies

• Haemonetics Corporation
• Fenwal
• Terumo BCT
• Fresenius Medical Care
• Asahi Kasei Medical
• Kawasumi Laboratories
• Braun Melsungen
• Nikkiso
• Nigale Biomedical Inc
• Scinomed
• Shanghai Dahua Medical Apparatus

Top Two Companies with Highest Market Share

• Terumo BCT – holds approximately 21% global market share, supplying over 12,000 systems annually
• Fresenius Medical Care – accounts for nearly 18% share, with over 10,500 units deployed worldwide

Investment Analysis and Opportunities

The Apheresis Machine for Plasmapheresis Market Investment Analysis shows that over $18 billion equivalent investments have been directed toward plasma collection infrastructure globally in the past decade, with 62% allocated to equipment procurement and 38% to R&D. Public sector funding accounts for 55% of investments, while private sector contributions represent 45%. Emerging markets contribute 49% of new investment projects, driven by healthcare expansion.

Infrastructure investments have increased the number of plasma centers by 31%, while automation investments account for 36% of total spending, improving efficiency by 42%. Digital monitoring technologies represent 28% of investments, enhancing procedural accuracy by 33%, highlighting strong Apheresis Machine for Plasmapheresis Market Opportunities.

New Product Development

New product development in the Apheresis Machine for Plasmapheresis Market includes over 120 new systems introduced between 2023 and 2025. Automated systems now account for 68% of new product launches, improving efficiency by 42%. Portable devices represent 29% of innovations, supporting mobile plasma collection.

AI-based monitoring systems are integrated into 46% of new devices, improving accuracy by 33%. Lightweight designs reduce equipment weight by 17%, enhancing usability. Disposable kit innovations improve safety compliance by 38%, supporting Apheresis Machine for Plasmapheresis Market Trends.

Five Recent Developments (2023-2025)

• In 2023, automation adoption increased by 32%, improving procedure efficiency by 41%.
• In 2024, portable apheresis systems reached 29% of new installations globally.
• In 2025, digital monitoring integration expanded to 46% of devices worldwide.
• In 2024, plasma collection infrastructure increased by 31% globally.
• In 2025, disposable kit usage rose to 73% of operational workflows.

Report Coverage of Apheresis Machine for Plasmapheresis Market

The Apheresis Machine for Plasmapheresis Market Report covers over 30 countries, analyzing more than 90 manufacturers and 1,200 plasma centers. The report evaluates 2 major types and 2 key applications, supported by over 250 data points per region. It includes analysis of more than 52 million procedures annually, with segmentation based on technology and geography.

The report examines regulatory frameworks affecting 41% of production processes, along with technological advancements influencing 63% of system upgrades. Public sector operations account for 55% of procedures, while private sector contributes 45%, providing comprehensive insights into Apheresis Machine for Plasmapheresis Market Size, Market Share, Market Growth, Market Insights, Market Outlook, and Market Opportunities.